Senior Specialist Global QMS

From the posting

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a commercial-stage biotechnology company redefining the transplant process by developing next-generation cell...

Read the full posting and apply on Remote OK →

Listed on Remote OK. First seen 25 Oct 2026, last confirmed 8 Nov 2026. Details may have changed: check the original before you apply.